1. Home
  2. TLX vs GTES Comparison

TLX vs GTES Comparison

Compare TLX & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLX
  • GTES
  • Stock Information
  • Founded
  • TLX 2015
  • GTES 1911
  • Country
  • TLX Australia
  • GTES United States
  • Employees
  • TLX N/A
  • GTES N/A
  • Industry
  • TLX Biotechnology: Pharmaceutical Preparations
  • GTES Industrial Machinery/Components
  • Sector
  • TLX Health Care
  • GTES Industrials
  • Exchange
  • TLX Nasdaq
  • GTES Nasdaq
  • Market Cap
  • TLX 5.7B
  • GTES 5.2B
  • IPO Year
  • TLX N/A
  • GTES 2018
  • Fundamental
  • Price
  • TLX $16.99
  • GTES $21.15
  • Analyst Decision
  • TLX Strong Buy
  • GTES Buy
  • Analyst Count
  • TLX 1
  • GTES 10
  • Target Price
  • TLX $22.00
  • GTES $22.70
  • AVG Volume (30 Days)
  • TLX 20.6K
  • GTES 1.9M
  • Earning Date
  • TLX 01-01-0001
  • GTES 04-30-2025
  • Dividend Yield
  • TLX N/A
  • GTES N/A
  • EPS Growth
  • TLX 798.14
  • GTES N/A
  • EPS
  • TLX 0.09
  • GTES 0.83
  • Revenue
  • TLX $484,687,790.00
  • GTES $3,393,200,000.00
  • Revenue This Year
  • TLX N/A
  • GTES $1.40
  • Revenue Next Year
  • TLX N/A
  • GTES $4.48
  • P/E Ratio
  • TLX $183.81
  • GTES $25.48
  • Revenue Growth
  • TLX 55.85
  • GTES N/A
  • 52 Week Low
  • TLX $13.61
  • GTES $14.70
  • 52 Week High
  • TLX $30.36
  • GTES $23.85
  • Technical
  • Relative Strength Index (RSI)
  • TLX N/A
  • GTES 56.54
  • Support Level
  • TLX N/A
  • GTES $20.39
  • Resistance Level
  • TLX N/A
  • GTES $21.80
  • Average True Range (ATR)
  • TLX 0.00
  • GTES 0.47
  • MACD
  • TLX 0.00
  • GTES -0.13
  • Stochastic Oscillator
  • TLX 0.00
  • GTES 33.52

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About GTES Gates Industrial Corporation plc

Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.

Share on Social Networks: